Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001205838 | SCV001377115 | pathogenic | Imerslund-Grasbeck syndrome | 2021-01-12 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with CUBN-related conditions. ClinVar contains an entry for this variant (Variation ID: 936927). This variant is present in population databases (rs374538208, ExAC 0.01%). This sequence change creates a premature translational stop signal (p.Trp2365*) in the CUBN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CUBN are known to be pathogenic (PMID: 15024727, 22929189). |
Fulgent Genetics, |
RCV002497701 | SCV002810437 | likely pathogenic | Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign | 2021-07-27 | criteria provided, single submitter | clinical testing |